 |
市場調査レポート
商品コード
1373832
動物用抗生剤および抗菌剤の世界市場 - 市場規模、シェア、成長分析：タイプ別、用途別 - 業界予測（2023年～2030年）Global Animal Antibiotics and Antimicrobials Market Size, Share, Growth Analysis, By Type(Penicillins, Tetracyclines), By Application(Veterinary Hospitals & Clinics, Veterinary Pharmacies) - Industry Forecast 2023-2030 |
||||||
| 動物用抗生剤および抗菌剤の世界市場 - 市場規模、シェア、成長分析：タイプ別、用途別 - 業界予測（2023年～2030年） |
|
出版日: 2023年10月20日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の動物用抗生剤および抗菌剤の市場規模は、2021年に43億2,000万米ドル、2022年に44億7,000万米ドルとなりました。同市場は、予測期間中（2023年～2030年）に3.5％でのCAGRで拡大し、2030年には58億9,000万米ドルに成長する見通しです。
世界の動物用抗生剤および抗菌剤市場は、動物の健康と福祉の増進を目的とする動物用医薬品産業の重要な構成要素です。世界の動物用抗生剤および抗菌剤市場の主な促進要因の一つは、動物性タンパク質に対する需要の増加です。世界人口の増加と可処分所得の増加に伴い、肉、牛乳、卵の消費量が大幅に増加しています。このため、家畜生産が拡大し、動物の感染症を予防・治療するための抗生物質や抗菌薬のニーズが高まっています。市場成長のもう一つの要因は、動物疾病の蔓延の増加です。呼吸器感染症、胃腸感染症、乳房炎などの感染症は、動物の健康と生産性に大きな脅威をもたらします。抗生物質と抗菌剤は、これらの疾病を制御・管理する上で重要な役割を果たしており、市場の需要に拍車をかけています。さらに、動物福祉と動物から人への疾病伝播の減少にますます焦点が当てられています。抗生物質と抗菌剤は、動物の健康と福祉を維持し、最適な成長と生産性を確保するために不可欠です。
鳥インフルエンザ、口蹄疫、豚熱のような動物の感染症の発生は、抗生物質と抗菌剤を使用して病気の蔓延を制御し、防止する必要性を強調しています。疾病の発生に伴う潜在的な経済的損失は、特にそのような疾病の流行が高い地域において、これらの製品に対する需要を牽引しています。この需要は、家畜の健康を守り、畜産業の生産性を維持する必要性から生じています。
消費者の嗜好が変化し、食品の安全性と持続可能性に関する意識が高まった結果、抗生物質不使用の動物用製品に対する需要が増加しています。このような消費者行動の変化は、生産者が抗生物質不使用の生産システムを採用する動機となり、動物用抗生物質と抗菌剤の需要に悪影響を及ぼしています。生産者は、持続可能性と抗生物質使用量の削減に重点を置きながら、動物の疾病予防と成長促進に対する代替アプローチを模索することで、消費者の期待に応え、市場の動向に合わせようと努力しています。
当レポートは、世界の動物用抗生剤および抗菌剤市場について調査し、市場の概要とともに、タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
エグゼクティブサマリー
親市場分析
市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 動向分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- 主要投資分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーターの分析
世界の動物用抗生剤および抗菌剤市場、タイプ別
- 市場概要
- ペニシリン
- テトラサイクリン系
- スルホンアミド
- マクロライド系
- アミノグリコシド
- フルオロキノロン類、その他
世界の動物用抗生剤および抗菌剤市場、用途別
- 市場概要
- 動物病院、クリニック
- 動物薬局
- オンライン薬局
世界の動物用抗生剤および抗菌剤市場、地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
競合情勢
- 主要企業プロファイル
- Zoetis Inc.
- Merck Animal Health
- Elanco Animal Health
- Boehringer Ingelheim Animal Health
- Ceva Sante Animale
- Vetoquinol S.A.
- Bayer Animal Health
- Virbac
- Dechra Pharmaceuticals
- Norbrook Laboratories Ltd.
- Huvepharma
- Phibro Animal Health Corporation
- China Animal Husbandry Co., Ltd.
- Hester Biosciences Limited
- Indian Immunologicals Ltd.
- Hipra
- Bimeda Holdings Plc
- Kyoritsu Seiyaku Corporation
- Vetoquinol
- Ouro Fino Saude Animal
Global Animal Antibiotics and Antimicrobials Market size was valued at USD 4.32 billion in 2021 and is poised to grow from USD 4.47 billion in 2022 to USD 5.89 billion by 2030, growing at a CAGR of 3.5% in the forecast period (2023-2030).
The global animal antibiotics and antimicrobials market is a vital component of the veterinary pharmaceutical industry, aimed at promoting animal health and welfare. One of the primary drivers of the global animal antibiotics and antimicrobials market is the increasing demand for animal protein. With the growing global population and rising disposable incomes, there has been a significant rise in the consumption of meat, milk, and eggs. This has led to the expansion of livestock production, thereby driving the need for antibiotics and antimicrobials to prevent and treat infectious diseases in animals. Another factor contributing to market growth is the rising prevalence of animal diseases. Infectious diseases, such as respiratory infections, gastrointestinal infections, and mastitis, pose a significant threat to animal health and productivity. Antibiotics and antimicrobials play a crucial role in controlling and managing these diseases, thus fueling the demand in the market. Moreover, there is an increasing focus on animal welfare and the reduction of disease transmission from animals to humans. Antibiotics and antimicrobials are essential in maintaining the health and well-being of animals, ensuring their optimal growth and productivity.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Animal Antibiotics And Antimicrobials Market Segmental Analysis
The global animal antibiotics and antimicrobials market is segmented based on type, application, and region. Based on type, the market can be segmented into Penicillins, Tetracyclines, Sulfonamides, Macrolides, Aminoglycosides, Fluoroquinolones, and Others. Based on application, the market is segmented into Veterinary Hospitals & Clinics, Veterinary Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Animal Antibiotics And Antimicrobials Market Dynamics
Drivers of the Global Animal Antibiotics And Antimicrobials Market
Disease Outbreaks and Epidemics
The occurrence of infectious diseases among animals, such as avian influenza, foot-and-mouth disease, and swine fever, underscores the necessity of using antibiotics and antimicrobials to control and prevent the spread of diseases. The potential economic losses associated with disease outbreaks drive the demand for these products, particularly in regions where the prevalence of such diseases is high. This demand stems from the need to protect animal health and maintain productivity within the livestock industry.
Restraints in the Global Animal Antibiotics And Antimicrobials Market
Consumer Preference for Antibiotic-Free Products
Evolving consumer preferences and a heightened awareness regarding food safety and sustainability have resulted in an increased demand for antibiotic-free animal products. This shift in consumer behaviour has motivated producers to adopt antibiotic-free production systems, which in turn has had a negative impact on the demand for animal antibiotics and antimicrobials. Producers are striving to meet consumer expectations and align with market trends by exploring alternative approaches to disease prevention and growth promotion in animals, with a focus on sustainability and reduced antibiotic usage.
Market Trends for Global Animal Antibiotics And Antimicrobials Key
Growing Emphasis on Antibiotic Alternatives and Responsible Use of Antimicrobials. With the rising concerns over antimicrobial resistance (AMR) and its impact on human and animal health, there is a shift towards reducing the use of antibiotics in animal production. This trend is driven by regulatory initiatives, consumer awareness, and a push from industry stakeholders to find effective alternatives that promote animal health while minimising the risk of AMR. Antibiotic alternatives such as probiotics, prebiotics, phytogenics, and vaccines are gaining traction as viable options to maintain animal health and improve performance.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Animal Antibiotics and Antimicrobials Market by Type
- Market Overview
- Penicillins
- Tetracyclines
- Sulfonamides
- Macrolides
- Aminoglycosides
- Fluoroquinolones and Others.
- Global Animal Antibiotics and Antimicrobials Market by Application
- Market Overview
- Veterinary Hospitals & Clinics
- Veterinary Pharmacies
- Online Pharmacies and Others.
- Global Animal Antibiotics and Antimicrobials Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Zoetis Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck Animal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elanco Animal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim Animal Health (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ceva Sante Animale (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vetoquinol S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer Animal Health (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Virbac (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dechra Pharmaceuticals (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Norbrook Laboratories Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Huvepharma (Bulgaria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Phibro Animal Health Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- China Animal Husbandry Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hester Biosciences Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Indian Immunologicals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hipra (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bimeda Holdings Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kyoritsu Seiyaku Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vetoquinol (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ouro Fino Saude Animal (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
